Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
34
IQV Quote, Financials, Valuation and Earnings
Last price:
$165.58
Seasonality move
:
-2.67%
Day range:
$163.62 - $169.34
52-week range:
$134.65 - $247.05
Dividend yield:
0%
P/E ratio:
21.08x
P/S ratio:
1.76x
P/B ratio:
4.32x
Volume:
2.6M
Avg. volume:
2.3M
1-year change:
-14.63%
Market cap:
$28.1B
Revenue:
$16.3B
EPS (TTM):
$7.86
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IQV
IQVIA Holdings, Inc.
|
$4.2B | $3.02 | 7.11% | 101.42% | $237.75 |
|
AIRS
AirSculpt Technologies, Inc.
|
$43.1M | $0.01 | -10.84% | -65.36% | $6.00 |
|
CVS
CVS Health Corp.
|
$100B | $1.83 | 1.11% | 59.17% | $94.84 |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- |
|
WORX
SCWorx Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IQV
IQVIA Holdings, Inc.
|
$165.62 | $237.75 | $28.1B | 21.08x | $0.00 | 0% | 1.76x |
|
AIRS
AirSculpt Technologies, Inc.
|
$1.88 | $6.00 | $117.4M | 300.71x | $0.00 | 0% | 0.71x |
|
CVS
CVS Health Corp.
|
$76.69 | $94.84 | $97.6B | 55.43x | $0.67 | 3.47% | 0.24x |
|
FPCG
First Physicians Capital Group, Inc.
|
$1,025.00 | -- | $10M | -- | $0.00 | 0% | 1.42x |
|
UNVC
UNIVEC
|
$0.0025 | -- | $453K | -- | $0.00 | 0% | -- |
|
WORX
SCWorx Corp.
|
$0.43 | -- | $6.7M | -- | $0.00 | 0% | 0.63x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IQV
IQVIA Holdings, Inc.
|
71.43% | 1.042 | 42.39% | 0.67x |
|
AIRS
AirSculpt Technologies, Inc.
|
51.18% | 10.736 | 17.19% | 0.22x |
|
CVS
CVS Health Corp.
|
51.53% | -0.370 | 79.13% | 0.48x |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | 0.000 | -- | -- |
|
UNVC
UNIVEC
|
-- | 1.393 | -- | -- |
|
WORX
SCWorx Corp.
|
0.05% | 2.106 | 0.08% | 1.15x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IQV
IQVIA Holdings, Inc.
|
$1.1B | $646M | 6.37% | 22.13% | 14.82% | $561M |
|
AIRS
AirSculpt Technologies, Inc.
|
$16.9M | -$1.3M | -10.01% | -21.8% | -3.72% | -$405K |
|
CVS
CVS Health Corp.
|
$13.6B | $2.3B | 1.1% | 2.28% | 2.19% | $2.6B |
|
FPCG
First Physicians Capital Group, Inc.
|
-- | -- | -- | -- | -- | -- |
|
UNVC
UNIVEC
|
-- | -- | -- | -- | -- | -- |
|
WORX
SCWorx Corp.
|
$119.1K | -$138.9K | -74.13% | -74.77% | -19.68% | -$358.1K |
IQVIA Holdings, Inc. vs. Competitors
-
Which has Higher Returns IQV or AIRS?
AirSculpt Technologies, Inc. has a net margin of 11.79% compared to IQVIA Holdings, Inc.'s net margin of -27.18%. IQVIA Holdings, Inc.'s return on equity of 22.13% beat AirSculpt Technologies, Inc.'s return on equity of -21.8%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings, Inc.25.56% $2.99 $22.9B AIRSAirSculpt Technologies, Inc.48.33% -$0.15 $168.2M -
What do Analysts Say About IQV or AIRS?
IQVIA Holdings, Inc. has a consensus price target of $237.75, signalling upside risk potential of 43.55%. On the other hand AirSculpt Technologies, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 219.15%. Given that AirSculpt Technologies, Inc. has higher upside potential than IQVIA Holdings, Inc., analysts believe AirSculpt Technologies, Inc. is more attractive than IQVIA Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings, Inc.16 5 0 AIRSAirSculpt Technologies, Inc.0 2 0 -
Is IQV or AIRS More Risky?
IQVIA Holdings, Inc. has a beta of 1.367, which suggesting that the stock is 36.713% more volatile than S&P 500. In comparison AirSculpt Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IQV or AIRS?
IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AirSculpt Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. AirSculpt Technologies, Inc. pays out 3.05% of its earnings as a dividend. AirSculpt Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios IQV or AIRS?
IQVIA Holdings, Inc. quarterly revenues are $4.4B, which are larger than AirSculpt Technologies, Inc. quarterly revenues of $35M. IQVIA Holdings, Inc.'s net income of $514M is higher than AirSculpt Technologies, Inc.'s net income of -$9.5M. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 21.08x while AirSculpt Technologies, Inc.'s PE ratio is 300.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 1.76x versus 0.71x for AirSculpt Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings, Inc.1.76x 21.08x $4.4B $514M AIRSAirSculpt Technologies, Inc.0.71x 300.71x $35M -$9.5M
-
Which has Higher Returns IQV or CVS?
CVS Health Corp. has a net margin of 11.79% compared to IQVIA Holdings, Inc.'s net margin of 2.77%. IQVIA Holdings, Inc.'s return on equity of 22.13% beat CVS Health Corp.'s return on equity of 2.28%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings, Inc.25.56% $2.99 $22.9B CVSCVS Health Corp.12.82% $2.30 $155.3B -
What do Analysts Say About IQV or CVS?
IQVIA Holdings, Inc. has a consensus price target of $237.75, signalling upside risk potential of 43.55%. On the other hand CVS Health Corp. has an analysts' consensus of $94.84 which suggests that it could grow by 23.67%. Given that IQVIA Holdings, Inc. has higher upside potential than CVS Health Corp., analysts believe IQVIA Holdings, Inc. is more attractive than CVS Health Corp..
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings, Inc.16 5 0 CVSCVS Health Corp.16 5 0 -
Is IQV or CVS More Risky?
IQVIA Holdings, Inc. has a beta of 1.367, which suggesting that the stock is 36.713% more volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.496, suggesting its less volatile than the S&P 500 by 50.368%.
-
Which is a Better Dividend Stock IQV or CVS?
IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.47% to investors and pays a quarterly dividend of $0.67 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or CVS?
IQVIA Holdings, Inc. quarterly revenues are $4.4B, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. IQVIA Holdings, Inc.'s net income of $514M is lower than CVS Health Corp.'s net income of $2.9B. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 21.08x while CVS Health Corp.'s PE ratio is 55.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 1.76x versus 0.24x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings, Inc.1.76x 21.08x $4.4B $514M CVSCVS Health Corp.0.24x 55.43x $105.7B $2.9B
-
Which has Higher Returns IQV or FPCG?
First Physicians Capital Group, Inc. has a net margin of 11.79% compared to IQVIA Holdings, Inc.'s net margin of --. IQVIA Holdings, Inc.'s return on equity of 22.13% beat First Physicians Capital Group, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings, Inc.25.56% $2.99 $22.9B FPCGFirst Physicians Capital Group, Inc.-- -- -- -
What do Analysts Say About IQV or FPCG?
IQVIA Holdings, Inc. has a consensus price target of $237.75, signalling upside risk potential of 43.55%. On the other hand First Physicians Capital Group, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than First Physicians Capital Group, Inc., analysts believe IQVIA Holdings, Inc. is more attractive than First Physicians Capital Group, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings, Inc.16 5 0 FPCGFirst Physicians Capital Group, Inc.0 0 0 -
Is IQV or FPCG More Risky?
IQVIA Holdings, Inc. has a beta of 1.367, which suggesting that the stock is 36.713% more volatile than S&P 500. In comparison First Physicians Capital Group, Inc. has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.813%.
-
Which is a Better Dividend Stock IQV or FPCG?
IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. First Physicians Capital Group, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or FPCG?
IQVIA Holdings, Inc. quarterly revenues are $4.4B, which are larger than First Physicians Capital Group, Inc. quarterly revenues of --. IQVIA Holdings, Inc.'s net income of $514M is higher than First Physicians Capital Group, Inc.'s net income of --. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 21.08x while First Physicians Capital Group, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 1.76x versus 1.42x for First Physicians Capital Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings, Inc.1.76x 21.08x $4.4B $514M FPCGFirst Physicians Capital Group, Inc.1.42x -- -- --
-
Which has Higher Returns IQV or UNVC?
UNIVEC has a net margin of 11.79% compared to IQVIA Holdings, Inc.'s net margin of --. IQVIA Holdings, Inc.'s return on equity of 22.13% beat UNIVEC's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings, Inc.25.56% $2.99 $22.9B UNVCUNIVEC-- -- -- -
What do Analysts Say About IQV or UNVC?
IQVIA Holdings, Inc. has a consensus price target of $237.75, signalling upside risk potential of 43.55%. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than UNIVEC, analysts believe IQVIA Holdings, Inc. is more attractive than UNIVEC.
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings, Inc.16 5 0 UNVCUNIVEC0 0 0 -
Is IQV or UNVC More Risky?
IQVIA Holdings, Inc. has a beta of 1.367, which suggesting that the stock is 36.713% more volatile than S&P 500. In comparison UNIVEC has a beta of -0.101, suggesting its less volatile than the S&P 500 by 110.112%.
-
Which is a Better Dividend Stock IQV or UNVC?
IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or UNVC?
IQVIA Holdings, Inc. quarterly revenues are $4.4B, which are larger than UNIVEC quarterly revenues of --. IQVIA Holdings, Inc.'s net income of $514M is higher than UNIVEC's net income of --. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 21.08x while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 1.76x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings, Inc.1.76x 21.08x $4.4B $514M UNVCUNIVEC-- -- -- --
-
Which has Higher Returns IQV or WORX?
SCWorx Corp. has a net margin of 11.79% compared to IQVIA Holdings, Inc.'s net margin of -185.96%. IQVIA Holdings, Inc.'s return on equity of 22.13% beat SCWorx Corp.'s return on equity of -74.77%.
Company Gross Margin Earnings Per Share Invested Capital IQVIQVIA Holdings, Inc.25.56% $2.99 $22.9B WORXSCWorx Corp.16.88% -$0.15 $6M -
What do Analysts Say About IQV or WORX?
IQVIA Holdings, Inc. has a consensus price target of $237.75, signalling upside risk potential of 43.55%. On the other hand SCWorx Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that IQVIA Holdings, Inc. has higher upside potential than SCWorx Corp., analysts believe IQVIA Holdings, Inc. is more attractive than SCWorx Corp..
Company Buy Ratings Hold Ratings Sell Ratings IQVIQVIA Holdings, Inc.16 5 0 WORXSCWorx Corp.0 0 0 -
Is IQV or WORX More Risky?
IQVIA Holdings, Inc. has a beta of 1.367, which suggesting that the stock is 36.713% more volatile than S&P 500. In comparison SCWorx Corp. has a beta of 2.149, suggesting its more volatile than the S&P 500 by 114.918%.
-
Which is a Better Dividend Stock IQV or WORX?
IQVIA Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SCWorx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IQVIA Holdings, Inc. pays -- of its earnings as a dividend. SCWorx Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IQV or WORX?
IQVIA Holdings, Inc. quarterly revenues are $4.4B, which are larger than SCWorx Corp. quarterly revenues of $705.8K. IQVIA Holdings, Inc.'s net income of $514M is higher than SCWorx Corp.'s net income of -$1.3M. Notably, IQVIA Holdings, Inc.'s price-to-earnings ratio is 21.08x while SCWorx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IQVIA Holdings, Inc. is 1.76x versus 0.63x for SCWorx Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IQVIQVIA Holdings, Inc.1.76x 21.08x $4.4B $514M WORXSCWorx Corp.0.63x -- $705.8K -$1.3M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
